Long term license agreement signed for Intrarosa®

Avia Pharma has signed a long-term license agreement with Endoceutics for the Nordic commercial rights to Intrarosa®. Intrarosa® is locally administered for the treatment of vaginal atrophy. Intrarosa® contains prasterone, an inactive steroid hormone that is converted locally inside the vaginal cells into androgens and estrogens. This intracellular production does…

ACO vitamin D now without palm oil

The Swedish MPA has approved a new formulation of ACO Vitamin D without palm oil. Palm oil has negative impact on the environment and the Swedish Food agency recommends parents not to give their children any food products containing palm oil. ACO Vitamin D drops is the only pharmaceutical without…

New design and pack size for Duroferon

Avia Pharma has developed a more contemporary package for Duroferon on the Swedish market. The new design affects the 100-tablet blister, the 200-tablet blister and the 100-tablet plastic container. A 60-tablet blister pack has also been introduced on the market. “We are continuously investing in our products and this is…

Avia Pharma appoints Jonas Karlander as CFO

Avia Pharma appoints Jonas Karlander as CFO. Jonas Karlander has for the last 20 years been working in different controlling and finance positions in multiple industries. “We are very pleased that Jonas Karlander has decided to join Avia Pharma. He will strengthen our capabilities, not only in controlling/finance, but also…